ALLIANCE A091305

Primary Category:

Treatment Protocols

Disease Category:

Thyroid

Status:

Closed

A Phase 2 Study of Efatutazone, an Oral PPAR Agonist, In Combination with Paclitaxel in Patients with Advanced Anaplastic Thyroid Cancer

NCT#02152137